Abstract
The reactivities of two panels of anti-HAV human sera from geographically distinct areas (Chile and Spain) to synthetic peptides from the VP1, VP2 and VP3 hepatitis A virus capsid proteins were examined by an enzyme-linked immunosorbent assay (ELISA) procedure. Two and four branched multiple antigenic peptides (MAPs) and palmitoylated peptides were compared with free synthetic sequences for the detection of IgM anti-HAV antibodies in the two panels of human sera. Our results showed that acute hepatitis A patient sera recognized preferentially homogeneous two branched MAPs and palmitic acid conjugated peptides. The palmitoyl-derived VP3(110-121) peptide and the corresponding dimeric MAP were the most sensitive and appropriate for serological studies of HAV-infected patients by ELISA, sensitivity and specificity being higher than 90% and 95%, respectively. These peptide-based tests open up new avenues in the development of peptide-based immunosorbent assays for the detection of acute HAV disease.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acute Disease
-
Antigens, Viral / immunology*
-
Capsid / chemical synthesis
-
Capsid / immunology*
-
Capsid Proteins
-
Enzyme-Linked Immunosorbent Assay / methods
-
Epitopes, B-Lymphocyte / immunology
-
Hepatitis A / blood
-
Hepatitis A / diagnosis*
-
Hepatitis A / immunology
-
Hepatitis A Antibodies
-
Hepatitis A Antigens
-
Hepatitis Antibodies / blood
-
Hepatitis Antibodies / immunology
-
Humans
-
Immunologic Tests / methods
-
Palmitic Acid / immunology
-
Peptide Fragments / chemical synthesis
-
Peptide Fragments / immunology*
-
Peptides / chemical synthesis
-
Peptides / immunology
-
Reagent Kits, Diagnostic
-
Reproducibility of Results
-
Sensitivity and Specificity
-
Viral Structural Proteins / chemical synthesis
-
Viral Structural Proteins / immunology*
Substances
-
Antigens, Viral
-
Capsid Proteins
-
Epitopes, B-Lymphocyte
-
Hepatitis A Antibodies
-
Hepatitis A Antigens
-
Hepatitis Antibodies
-
Peptide Fragments
-
Peptides
-
Reagent Kits, Diagnostic
-
VP1 protein, hepatitis A virus
-
VP3 peptide (110-121), hepatitis A virus
-
Viral Structural Proteins
-
Palmitic Acid